Ziwig Biotech Launches Groundbreaking Endometriosis Saliva Test – FINN Partners
FINN Partners shared a post on LinkedIn:
“Major announcement from FINN client Ziwig Biotech: Ziwig Endotest, the world’s first endometriosis saliva test, has received marketing authorization in the United States.
Endometriosis is a disease that affects 190 million women worldwide, nearly one in ten women of reproductive age. This news marks a major new step toward global access to endometriosis diagnosis.
Our recent Ziwig press conference showcased a remarkable journey, from a breakthrough innovation to a scientifically validated and globally deployed solution.
Key milestones achieved:
- Publication of the ENDOmiRNA study results in NEJM Evidence (Nov. 2025), the world’s first validation of a salivary biomarker for endometriosis
- Deployment of Ziwig Endotest in 37 countries
- ENDOBEST study: patient recruitment completed in France (2,500 patients), with a total of more than 25,000 women already benefiting from early access to the test in Ziwig’s country of origin
Research at the core of the vision. Beyond endometriosis, Ziwig is expanding its salivary RNA technology to other high–public health–impact conditions, including:
- multiple gynecological pathologies (the GYNARN study),
- ovarian cancer (the OVARN study),
- and ALS – Charcot disease (the SLARN study, inclusion completed).
Ziwig continues to show its unwavering commitment to transforming healthcare: precision, predictive, and accessible medicine is becoming a reality, powered by cutting-edge science, AI, and a patient-first global vision.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Mar 12, 2026, 14:29Fahima Hussain: When Reproductive Trauma Goes Unspoken
-
Mar 12, 2026, 12:56Vinnie Arvin Amir: New AI Study Explores Immune Factors in Pregnancy Loss
-
Mar 12, 2026, 12:53Deep Learning Bridges the Diagnostic Gap in Chronic Endometritis – Medicina MDPI
-
Mar 12, 2026, 12:49Explore the ASRM CELL Training Lab – ASRM
-
Mar 12, 2026, 02:28Anthony Griffiths to Discuss Multidisciplinary Approaches to Endometriosis Care – BSGI
-
Mar 11, 2026, 12:36Christopher Robinson: B-Lynch Uterine Compression Technique Discussed in AJOG Expert Review
-
Mar 11, 2026, 09:55Abstract Deadline and Early Registration Approaching for ESHRE Embryology 2026 – ESHRE
-
Mar 11, 2026, 08:57How Hyaluronic Acid Medium Improves Live Birth Rate? – RBMO
-
Mar 11, 2026, 08:46PCOS and Higher BMI Linked to Increased Risk of Type 2 Diabetes – Fertility and Sterility